机构ID,机构名称,公告日期,截止日期,报告年度,合并类型,报表来源,货币资金（元）,以公允价值计量且其变动计入当期损益的金融资产,应收票据,应收账款,预付款项,其他应收款,应收关联公司款,应收利息,应收股利,存货,其中：消耗性生物资产,一年内到期的非流动资产,其他流动资产,流动资产合计,可供出售金融资产,持有至到期投资,长期应收款,长期股权投资,投资性房地产,固定资产,在建工程,工程物资,固定资产清理,生产性生物资产,油气资产,无形资产,开发支出,商誉,长期待摊费用,递延所得税资产,其他非流动资产,非流动资产合计,资产总计,短期借款,以公允价值计量且其变动计入当期损益的金融负债,应付票据,应付账款,预收款项,应付职工薪酬,应交税费,应付利息,应付股利,其他应付款,应付关联公司款,一年内到期的非流动负债,其他流动负债,流动负债合计,长期借款,应付债券,长期应付款,专项应付款,预计负债,递延所得税负债,其他非流动负债,非流动负债合计,负债合计,实收资本（或股本）,资本公积,盈余公积,专项储备,减：库存股,一般风险准备,未分配利润,归属于母公司所有者权益,少数股东权益,外币报表折算价差,非正常经营项目收益调整,所有者权益（或股东权益）合计,负债和所有者（或股东权益）合计,其他综合收益,递延收益-非流动负债,结算备付金,拆出资金,发放贷款及垫款-流动资产,衍生金融资产,应收保费,应收分保账款,应收分保合同准备金,买入返售金融资产,划分为持有待售的资产,发放贷款及垫款-非流动资产,向中央银行借款,吸收存款及同业存放,拆入资金,衍生金融负债,卖出回购金融资产款,应付手续费及佣金,应付分保账款,保险合同准备金,代理买卖证券款,代理承销证券款,划分为持有待售的负债,预计负债-流动负债,递延收益-流动负债,其中：优先股-非流动负债,永续债-非流动负债,长期应付职工薪酬,其他权益工具,其中：优先股-所有者权益,永续债-所有者权益
300653,正海生物,2017-05-15,2017-03-31,2017-03-31,合并本期,上市公告书,110647770.45,,800000,36374459.09,1102166.96,690722.69,,,,6365104.7,,,40014317.47,195994541.36,,,,,,22991681.05,415328,,,,,18126545.22,,,26650.44,1524594.27,27782685,70867483.98,266862025.34,,,,7850998.42,2301089.72,3498400.43,890371.15,,,4919769.63,,,0.0,19460629.35,,,,,124670.87,,0.0,10639420.95,30100050.3,60000000,96887248.18,7470585.31,,,,72404141.55,236761975.04,,,0.0,236761975.04,266862025.34,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
300653,正海生物,2017-08-02,2017-06-30,2017-06-30,合并本期,定期报告,259801859.65,,1050000,41064031.83,338871.22,420727.17,,338828.22,,6403486.26,,,96111681.03,405529485.38,,,,,,23325681.54,1708240,,,,,18702807.14,,,,2190922.02,26303110,72230760.7,477760246.08,,,,9324658.22,552531.51,3438878.69,2517096.26,,,5105811.04,,,,20938975.72,,,,,88171.26,,,14420439.48,35359415.2,80000000,269418284.73,7470585.31,,,,85511960.84,442400830.88,,,,442400830.88,477760246.08,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
